You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 3, March 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal


Patients With Truncal Basal Cell Carcinoma Represent a High-Risk Group

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In a recent issue of the ARCHIVES, McCormack et al1 describe patients with superficial basal cell carcinoma (BCC) who had a significantly lower mean age at diagnosis than those with other subtypes and that 73.3% of superficial BCCs occur on the trunk.1 We have investigated the role of polymorphism in various detoxifying enzymes on the risk of BCC. In particular, we have assessed the role of glutathione S-transferases (GST, GSTM1, and GSTT1).2-4 These are good candidates for BCC pathogenesis since they play a role in the defense against UV-induced oxidative stress damage to the skin.2-3

We recently assessed the implications of the truncal site of BCC as it relates to the risk of disease. We recruited, interviewed, genotyped, and followed up a cohort of patients with BCC. Patients with a truncal BCC at presentation were more likely to have multiple tumors (P=.002; odds ratio, 4.03)5 and were . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.